REPEAT & CORRECT : Amazon Launches Program for GLP-1 Weight-Loss Drugs Article on April 21

Published: 2026-04-22 09:20:20 ET AMZN

Published on 04/22/2026 at 09:20 am EDT

Amazon is offering a GLP-1 weight loss program that doesn't require membership. "Amazon.com to Offer Program for GLP-1 Weight-Loss Drugs," published at 3:15 p.m. on April 21, implied that members can explore or enroll in the program. The correct version follows:

By Kelly Cloonan

Amazon.com is offering a GLP-1 weight-loss program that integrates primary-care services with the technology company's pharmacy business.

The company said Tuesday the new program is designed to provide continuing medical supervision--allowing clinicians to monitor progress, adjust treatments and address related health conditions--compared with one-off weight-management solutions from other providers.

With the program, customers can get Novo Nordisk's Wegovy and Eli Lilly's Foundayo GLP-1 pills for weight management starting at $25 a month with insurance coverage, or $149 a month for cash-pay options.

The $149 cash-pay price for a starter dose aligns with those offered through programs from the likes of Hims & Hers Health, Walgreens and Weight Watchers.

Amazon One Medical membership is not required to explore or enroll in the program, including for in-person care or scheduled remote visits, the company said.

Amazon Pharmacy also provides injectable versions of Wegovy and Lilly's Zepbound. It currently offers same-day delivery for all medications to nearly 3,000 cities and towns, and said it plans to expand to nearly 4,500 by the end of 2026.

"By expanding access to the latest GLP-1 medications with upfront, clear pricing, we're making it easier for customers to get the treatments their health care providers prescribe and to stay on those medications because they are delivered reliably directly to patients," said Tanvi Patel, vice president and general manager of Amazon Pharmacy.

Shares of Hims & Hers fell 3.9%, to $29.79, on Tuesday. Weight Watchers declined 9%, and Novo Nordisk fell 2.6%.

Under Amazon's new GLP-1 program, patients would receive pre-visit screening, consultations and follow-up visits with integrated monitoring, standardized documentation and treatment algorithms. It is available at Amazon One Medical locations across the U.S., the company said.

Customers who aren't Amazon One Medical primary care patients can also get prescription renewals through on-demand telehealth services, starting at $29 for message consultations or $49 for video care.

Write to Kelly Cloonan at [email protected]

(END) Dow Jones Newswires

04-22-26 0919ET